Catalyst Wire Dossier Catalyst Wire Dossier

ABCB5-positive limbal stem cells

ABCB5-positive limbal stem cells · RHEACELL GmbH & Co. KG
Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for ABCB5-positive limbal stem cells, covering 2022-10-07 to 2022-10-07. Get the full timeline:

Most recent: Clinical Trial Update: Allogeneic ABCB5-positive Limbal Stem Cells for Treatment of LSCD [Phase 1, Phase 2]

See pricing